We are live on ! Find out more
MAM

Morse Asset Management Portfolio holdings

AUM $481M
1-Year Est. Return 46%
This Fund
S&P 500
This Quarter Est. Return
+5.47%
1 Year Est. Return
+46%
3 Year Est. Return
+152.98%
5 Year Est. Return
+238.35%
10 Year Est. Return
AUM
$438M
AUM Growth
-$25.6M
Cap. Flow
-$29.9M
Cap. Flow %
-6.82%
Top 10 Hldgs %
35.86%
Holding
383
New
41
Increased
96
Reduced
105
Closed
53

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.15M
2
ALAB icon
Astera Labs
ALAB
+$2.89M
3
GS icon
Goldman Sachs
GS
+$2.72M
4
VST icon
Vistra
VST
+$2.04M
5
DELL icon
Dell
DELL
+$1.54M

Sector Composition

Rank Sector Weight
1 Technology 29.69%
2 Consumer Discretionary 13.68%
3 Financials 10.74%
4 Healthcare 10.57%
5 Communication Services 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
51
Sherwin-Williams
SHW
$82.7B
$2.37M 0.54%
6,961
+4
+0.1% +$1.49K
ADP icon
52
Automatic Data Processing
ADP
$106B
$2.28M 0.52%
7,800
TLT icon
53
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$2.28M 0.52%
26,115
-3,736
-13% -$344K
MRK icon
54
Merck
MRK
$322B
$2.21M 0.5%
22,204
-5,200
-19% -$536K
NXPI icon
55
NXP Semiconductors
NXPI
$57.8B
$2.19M 0.5%
10,525
-895
-8% -$204K
CRH icon
56
CRH
CRH
$63.2B
$2.11M 0.48%
22,805
+7,240
+47% +$697K
FTI icon
57
TechnipFMC
FTI
$28.6B
$2.04M 0.47%
70,443
+2,868
+4% +$81.6K
DD icon
58
DuPont de Nemours
DD
$18.5B
$2.01M 0.46%
20,978
+1,143
+6% +$119K
CHY
59
Calamos Convertible and High Income Fund
CHY
$1.01B
$1.79M 0.41%
147,830
+17,307
+13% +$210K
DHI icon
60
D.R. Horton
DHI
$40B
$1.79M 0.41%
12,790
-4,973
-28% -$831K
DIS icon
61
Walt Disney
DIS
$167B
$1.74M 0.4%
15,663
-5,703
-27% -$599K
PLTR icon
62
Palantir
PLTR
$295B
$1.63M 0.37%
21,522
-28,435
-57% -$1.66M
HEI icon
63
HEICO Corp
HEI
$49.8B
$1.62M 0.37%
6,825
+673
+11% +$174K
HWM icon
64
Howmet Aerospace
HWM
$113B
$1.56M 0.36%
14,245
LRCX icon
65
Lam Research
LRCX
$367B
$1.54M 0.35%
21,270
-1,550
-7% -$118K
EBS icon
66
Emergent Biosolutions
EBS
$373M
$1.52M 0.35%
+158,819
New +$1.46M
BKR icon
67
Baker Hughes
BKR
$60B
$1.49M 0.34%
36,350
+1,400
+4% +$56.5K
SLG icon
68
SL Green Realty
SLG
$3.76B
$1.48M 0.34%
21,750
+475
+2% +$35.1K
TMO icon
69
Thermo Fisher Scientific
TMO
$213B
$1.45M 0.33%
2,787
-9,039
-76% -$4.97M
TT icon
70
Trane Technologies
TT
$101B
$1.41M 0.32%
3,814
-486
-11% -$193K
DDOG icon
71
Datadog
DDOG
$95.4B
$1.39M 0.32%
+9,697
New +$1.33M
CMI icon
72
Cummins
CMI
$87.5B
$1.33M 0.3%
3,801
REGN icon
73
Regeneron Pharmaceuticals
REGN
$78.5B
$1.32M 0.3%
1,855
-2,952
-61% -$2.48M
ABBV icon
74
AbbVie
ABBV
$443B
$1.3M 0.3%
7,313
-250
-3% -$46K
ISPY icon
75
ProShares S&P 500 High Income ETF
ISPY
$1.25B
$1.23M 0.28%
+27,865
New +$1.26M

Similar funds

Morse Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Morse Asset Management held 383 positions worth $438M, down 5.5% from $463M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Morse Asset Management withdrew a net $29.9M in Q4 2024, closing 53 positions and reducing 105 holdings. Its most notable exit was Alpha Architect 1-3 Month Box ETF, an estimated $2.07M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Morse Asset Management opened a new position in Emergent Biosolutions worth $1.52M.

  • Morse Asset Management's largest Q4 2024 buy was Emergent Biosolutions: 158,819 shares worth $1.52M.
  • Morse Asset Management added most to Bristol-Myers Squibb in Q4 2024, an estimated $3.15M increase.
  • Morse Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $8.45M.
  • Morse Asset Management fully exited Alpha Architect 1-3 Month Box ETF in Q4 2024, selling an estimated $2.07M.
  • Morse Asset Management's ten largest holdings make up 36% of its $438M portfolio in Q4 2024.
  • Morse Asset Management opened 41 new positions and closed 53 in Q4 2024.
  • Morse Asset Management's portfolio value fell 5.5% quarter-over-quarter to $438M.

Based on Morse Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.